These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12857416)
1. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Dvorin EL; Wylie-Sears J; Kaushal S; Martin DP; Bischoff J Tissue Eng; 2003 Jun; 9(3):487-93. PubMed ID: 12857416 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Sales VL; Engelmayr GC; Mettler BA; Johnson JA; Sacks MS; Mayer JE Circulation; 2006 Jul; 114(1 Suppl):I193-9. PubMed ID: 16820571 [TBL] [Abstract][Full Text] [Related]
3. Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering. Brugmans MM; Soekhradj-Soechit RS; van Geemen D; Cox M; Bouten CV; Baaijens FP; Driessen-Mol A Tissue Eng Part A; 2016 Jan; 22(1-2):123-32. PubMed ID: 26466917 [TBL] [Abstract][Full Text] [Related]
4. Poly-ε-caprolactone scaffold and reduced in vitro cell culture: beneficial effect on compaction and improved valvular tissue formation. Brugmans MM; Driessen-Mol A; Rubbens MP; Cox MA; Baaijens FP J Tissue Eng Regen Med; 2015 Dec; 9(12):E289-301. PubMed ID: 23677869 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. Sodian R; Hoerstrup SP; Sperling JS; Martin DP; Daebritz S; Mayer JE; Vacanti JP ASAIO J; 2000; 46(1):107-10. PubMed ID: 10667727 [TBL] [Abstract][Full Text] [Related]
6. Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures. Fu P; Sodian R; Lüders C; Lemke T; Kraemer L; Hübler M; Weng Y; Hoerstrup SP; Meyer R; Hetzer R ASAIO J; 2004; 50(1):9-14. PubMed ID: 14763486 [TBL] [Abstract][Full Text] [Related]
7. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. Klouda L; Vaz CM; Mol A; Baaijens FP; Bouten CV J Mater Sci Mater Med; 2008 Mar; 19(3):1137-44. PubMed ID: 17701317 [TBL] [Abstract][Full Text] [Related]
8. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep. Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878 [TBL] [Abstract][Full Text] [Related]
9. PGA (polyglycolic acid)-P4HB (poly-4-hydroxybutyrate)-Based Bioengineered Valves in the Rat Aortic Circulation. Książek AA; Mitchell KJ; Cesarovic N; Schwarzwald CC; Hoerstrup SP; Weber B J Heart Valve Dis; 2016 May; 25(3):380-388. PubMed ID: 27989051 [TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold. Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of poly-glycolic acid-based hybrid polymer starter matrices for in vitro tissue engineering. Generali M; Kehl D; Capulli AK; Parker KK; Hoerstrup SP; Weber B Colloids Surf B Biointerfaces; 2017 Oct; 158():203-212. PubMed ID: 28697435 [TBL] [Abstract][Full Text] [Related]
12. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
14. [Preparation of compound biodegradable matrices and growth of vascular endothelial cell on them]. Xiong M; Ai YF; Lu KH Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Sep; 16(5):303-6. PubMed ID: 12569799 [TBL] [Abstract][Full Text] [Related]
15. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Perry TE; Kaushal S; Sutherland FW; Guleserian KJ; Bischoff J; Sacks M; Mayer JE Ann Thorac Surg; 2003 Mar; 75(3):761-7; discussion 767. PubMed ID: 12645690 [TBL] [Abstract][Full Text] [Related]
16. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Paruchuri S; Yang JH; Aikawa E; Melero-Martin JM; Khan ZA; Loukogeorgakis S; Schoen FJ; Bischoff J Circ Res; 2006 Oct; 99(8):861-9. PubMed ID: 16973908 [TBL] [Abstract][Full Text] [Related]
17. Effect of transforming growth factor-beta and growth differentiation factor-5 on proliferation and matrix production by human bone marrow stromal cells cultured on braided poly lactic-co-glycolic acid scaffolds for ligament tissue engineering. Jenner JM; van Eijk F; Saris DB; Willems WJ; Dhert WJ; Creemers LB Tissue Eng; 2007 Jul; 13(7):1573-82. PubMed ID: 17518729 [TBL] [Abstract][Full Text] [Related]